These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 3437251
21. Effects of opioid agonists and antagonists on oxytocin and vasopressin release in vitro. Bicknell RJ, Chapman C, Leng G. Neuroendocrinology; 1985 Aug; 41(2):142-8. PubMed ID: 2864649 [Abstract] [Full Text] [Related]
22. Evidence for a role of opioid peptides in the release of arginine vasopressin in the conscious rat. Ishikawa S, Schrier RW. J Clin Invest; 1982 Mar; 69(3):666-72. PubMed ID: 6174549 [Abstract] [Full Text] [Related]
23. Naloxone increases the release of oxytocin, but not vasopressin, within limbic brain areas of conscious parturient rats: a push-pull perfusion study. Neumann I, Russell JA, Wolff B, Landgraf R. Neuroendocrinology; 1991 Dec; 54(6):545-51. PubMed ID: 1784342 [Abstract] [Full Text] [Related]
24. Release of oxytocin into blood and into cerebrospinal fluid induced by naloxone in anaesthetized morphine-dependent rats: the role of the paraventricular nucleus. Coombes JE, Robinson IC, Antoni FA, Russell JA. J Neuroendocrinol; 1991 Oct 01; 3(5):551-61. PubMed ID: 19215505 [Abstract] [Full Text] [Related]
25. Effect of chronic hyponatremia on central and peripheral oxytocin and vasopressin secretion in rats. Iványi T, Dohanics J, Verbalis JG. Neuroendocrinology; 1995 Apr 01; 61(4):412-20. PubMed ID: 7783854 [Abstract] [Full Text] [Related]
26. Endogenous opioid inhibition of the release of oxytocin from the isolated rat neurohypophysis during high-frequency stimulation of the pituitary stalk. Wammack R, Racké K. Neurosci Lett; 1988 Sep 23; 92(1):114-8. PubMed ID: 3185974 [Abstract] [Full Text] [Related]
27. Naloxone increases the angiotensin II stimulated rise of arginine vasopressin and oxytocin secretion in man. Coiro V, Chiodera P. Neuroendocrinology; 1991 Mar 23; 53(3):209-13. PubMed ID: 2041583 [Abstract] [Full Text] [Related]
28. Endogenous opioid mediation of somatostatin inhibition of arginine vasopressin release evoked by insulin-induced hypoglycemia in man. Chiodera P, Coiro V. J Neural Transm Gen Sect; 1991 Mar 23; 83(1-2):121-6. PubMed ID: 1673342 [Abstract] [Full Text] [Related]
31. Dynorphin A inhibits and naloxone increases the electrically stimulated release of oxytocin but not vasopressin from the terminals of the neural lobe. Bondy CA, Gainer H, Russell JT. Endocrinology; 1988 Apr 23; 122(4):1321-7. PubMed ID: 2894296 [Abstract] [Full Text] [Related]
32. Naloxone affects the release of cortisol, but not of vasopressin or oxytocin, in dehydrated sheep. Thornton SN, Parrott RF. Acta Endocrinol (Copenh); 1989 Jan 23; 120(1):50-4. PubMed ID: 2911940 [Abstract] [Full Text] [Related]
33. Opioids influence neurohypophysial but not central oxytocin release following direct hyperosmotic stimulation of the supraoptic nucleus in urethane-anaesthetised rats. Munro G, Ludwig M, Landgraf R, Russell JA. Neuropeptides; 1994 Aug 23; 27(2):121-7. PubMed ID: 7991066 [Abstract] [Full Text] [Related]
34. The posterior pituitary contains a potent prolactin-releasing factor: in vivo studies. Hyde JF, Ben-Jonathan N. Endocrinology; 1989 Aug 23; 125(2):736-41. PubMed ID: 2526728 [Abstract] [Full Text] [Related]
35. Vasopressin and oxytocin release as influenced by thyrotropin-releasing hormone in euhydrated and dehydrated rats. Ciosek J. J Physiol Pharmacol; 2002 Sep 23; 53(3):423-37. PubMed ID: 12369739 [Abstract] [Full Text] [Related]